INS and Hypoglycemia: Incidence and rates of hypoglycaemia were higher in TAKE CONTROL compared to ITAS, likely because of the greater hypoglycaemia risk (longer diabetes duration, antecedent insulin treatment in >60% of subjects, continued use of SU/glinides in TAKE CONTROL).